Science 1 July 1994: Vol. 265. no. 5168, pp. 92 - 95 DOI: 10.1126/science.8016657

Prev | Table of Contents | Next

Articles

Epstein-Barr Virus Nuclear Protein 3C Domains Necessary for Lymphoblastoid Cell Growth: Interaction with RBP-J{kappa} Regulates TCL1.

S. Lee, S. Sakakibara, S. Maruo, B. Zhao, M. A. Calderwood, A. M. Holthaus, C.-Y. Lai, K. Takada, E. Kieff, and E. Johannsen (2009)
J. Virol. 83, 12368-12377
 |  Abstract »  |  Full Text »  |  PDF »

Notch1, Notch2, and Epstein-Barr virus-encoded nuclear antigen 2 signaling differentially affects proliferation and survival of Epstein-Barr virus-infected B cells.

H. Kohlhof, F. Hampel, R. Hoffmann, H. Burtscher, U. H. Weidle, M. Holzel, D. Eick, U. Zimber-Strobl, and L. J. Strobl (2009)
Blood 113, 5506-5515
 |  Abstract »  |  Full Text »  |  PDF »

Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth.

S. Maruo, Y. Wu, T. Ito, T. Kanda, E. D. Kieff, and K. Takada (2009)
PNAS 106, 4419-4424
 |  Abstract »  |  Full Text »  |  PDF »

Epstein-Barr virus nuclear antigen 2 disrupts mitotic checkpoint and causes chromosomal instability.

S.-H. Pan, C.-C. Tai, C.-S. Lin, W.-B. Hsu, S.-F. Chou, C.-C. Lai, J.-Y. Chen, H.-F. Tien, F.-Y. Lee, and W.-B. Wang (2009)
Carcinogenesis 30, 366-375
 |  Abstract »  |  Full Text »  |  PDF »

Epigallocatechin-3-Gallate, a Histone Acetyltransferase Inhibitor, Inhibits EBV-Induced B Lymphocyte Transformation via Suppression of RelA Acetylation.

K.-C. Choi, M. G. Jung, Y.-H. Lee, J. C. Yoon, S. H. Kwon, H.-B. Kang, M.-J. Kim, J.-H. Cha, Y. J. Kim, W. J. Jun, et al. (2009)
Cancer Res. 69, 583-592
 |  Abstract »  |  Full Text »  |  PDF »

The LMP1 oncogene of EBV activates PERK and the unfolded protein response to drive its own synthesis.

D. Y. Lee and B. Sugden (2008)
Blood 111, 2280-2289
 |  Abstract »  |  Full Text »  |  PDF »

Chromatin Profiling of Epstein-Barr Virus Latency Control Region.

L. Day, C. M. Chau, M. Nebozhyn, A. J. Rennekamp, M. Showe, and P. M. Lieberman (2007)
J. Virol. 81, 6389-6401
 |  Abstract »  |  Full Text »  |  PDF »

Hsp72 up-regulates Epstein-Barr virus EBNALP coactivation with EBNA2.

C.-W. Peng, B. Zhao, H.-C. Chen, M.-L. Chou, C.-Y. Lai, S.-Z. Lin, H.-Y. Hsu, and E. Kieff (2007)
Blood 109, 5447-5454
 |  Abstract »  |  Full Text »  |  PDF »

Epstein-Barr virus and virus human protein interaction maps.

M. A. Calderwood, K. Venkatesan, L. Xing, M. R. Chase, A. Vazquez, A. M. Holthaus, A. E. Ewence, N. Li, T. Hirozane-Kishikawa, D. E. Hill, et al. (2007)
PNAS 104, 7606-7611
 |  Abstract »  |  Full Text »  |  PDF »

Epstein-Barr nuclear antigen leader protein coactivates transcription through interaction with histone deacetylase 4.

D. Portal, A. Rosendorff, and E. Kieff (2006)
PNAS 103, 19278-19283
 |  Abstract »  |  Full Text »  |  PDF »

The CR4 region of EBNA2 confers viability of Epstein-Barr virus-transformed B cells by CBF1-independent signalling..

K. Grabusic, S. Maier, A. Hartmann, A. Mantik, W. Hammerschmidt, and B. Kempkes (2006)
J. Gen. Virol. 87, 3169-3176
 |  Abstract »  |  Full Text »  |  PDF »

EBNA-3B- and EBNA-3C-Regulated Cellular Genes in Epstein-Barr Virus-Immortalized Lymphoblastoid Cell Lines..

A. Chen, B. Zhao, E. Kieff, J. C. Aster, and F. Wang (2006)
J. Virol. 80, 10139-10150
 |  Abstract »  |  Full Text »  |  PDF »

Epstein-Barr virus nuclear antigen 2 induces FcRH5 expression through CBF1.

J. Mohan, J. Dement-Brown, S. Maier, T. Ise, B. Kempkes, and M. Tolnay (2006)
Blood 107, 4433-4439
 |  Abstract »  |  Full Text »  |  PDF »

cdc2/Cyclin B1-Dependent Phosphorylation of EBNA2 at Ser243 Regulates Its Function in Mitosis.

W. Yue, J. Shackelford, and J. S. Pagano (2006)
J. Virol. 80, 2045-2050
 |  Abstract »  |  Full Text »  |  PDF »

Epstein-Barr Virus Nuclear Protein 3A Domains Essential for Growth of Lymphoblasts: Transcriptional Regulation through RBP-J{kappa}/CBF1 Is Critical.

S. Maruo, E. Johannsen, D. Illanes, A. Cooper, B. Zhao, and E. Kieff (2005)
J. Virol. 79, 10171-10179
 |  Abstract »  |  Full Text »  |  PDF »

A Somatic Knockout of CBF1 in a Human B-Cell Line Reveals that Induction of CD21 and CCR7 by EBNA-2 Is Strictly CBF1 Dependent and that Downregulation of Immunoglobulin M Is Partially CBF1 Independent.

S. Maier, M. Santak, A. Mantik, K. Grabusic, E. Kremmer, W. Hammerschmidt, and B. Kempkes (2005)
J. Virol. 79, 8784-8792
 |  Abstract »  |  Full Text »  |  PDF »

The Epstein-Barr Virus EBNA-LP Protein Preferentially Coactivates EBNA2-Mediated Stimulation of Latent Membrane Proteins Expressed from the Viral Divergent Promoter.

R. Peng, S. C. Moses, J. Tan, E. Kremmer, and P. D. Ling (2005)
J. Virol. 79, 4492-4505
 |  Abstract »  |  Full Text »  |  PDF »

Epstein-Barr virus nuclear antigen 2 induces interleukin-18 receptor expression in B cells.

F. Pages, J. Galon, G. Karaschuk, D. Dudziak, M. Camus, V. Lazar, S. Camilleri-Broet, C. Lagorce-Pages, S. Lebel-Binay, G. Laux, et al. (2005)
Blood 105, 1632-1639
 |  Abstract »  |  Full Text »  |  PDF »

Variable Methylation of the Epstein-Barr Virus Wp EBNA Gene Promoter in B-Lymphoblastoid Cell Lines.

J. Elliott, E. B. Goodhew, L. T. Krug, N. Shakhnovsky, L. Yoo, and S. H. Speck (2004)
J. Virol. 78, 14062-14065
 |  Abstract »  |  Full Text »  |  PDF »

Dynamic Chromatin Boundaries Delineate a Latency Control Region of Epstein-Barr Virus.

C. M. Chau and P. M. Lieberman (2004)
J. Virol. 78, 12308-12319
 |  Abstract »  |  Full Text »  |  PDF »

EBNA2 Is Required for Protection of Latently Epstein-Barr Virus-Infected B Cells against Specific Apoptotic Stimuli.

J. M. Lee, K.-H. Lee, C. J. Farrell, P. D. Ling, B. Kempkes, J. H. Park, and S. D. Hayward (2004)
J. Virol. 78, 12694-12697
 |  Abstract »  |  Full Text »  |  PDF »

Biophysical and Mutational Analysis of the Putative bZIP Domain of Epstein-Barr Virus EBNA 3C.

M. J. West, H. M. Webb, A. J. Sinclair, and D. N. Woolfson (2004)
J. Virol. 78, 9431-9445
 |  Abstract »  |  Full Text »  |  PDF »

Epstein-Barr Virus Latent Membrane Protein LMP-2A Is Sufficient for Transactivation of the Human Endogenous Retrovirus HERV-K18 Superantigen.

N. Sutkowski, G. Chen, G. Calderon, and B. T. Huber (2004)
J. Virol. 78, 7852-7860
 |  Abstract »  |  Full Text »  |  PDF »

RBP-J (CSL) Is Essential for Activation of the K14/vGPCR Promoter of Kaposi's Sarcoma-Associated Herpesvirus by the Lytic Switch Protein RTA.

Y. Liang and D. Ganem (2004)
J. Virol. 78, 6818-6826
 |  Abstract »  |  Full Text »  |  PDF »

CKII Site in Epstein-Barr Virus Nuclear Protein 2 Controls Binding to hSNF5/Ini1 and Is Important for Growth Transformation.

B. Kwiatkowski, S. Y. J. Chen, and W. H. Schubach (2004)
J. Virol. 78, 6067-6072
 |  Abstract »  |  Full Text »  |  PDF »

EBNA2 Amino Acids 3 to 30 Are Required for Induction of LMP-1 and Immortalization Maintenance.

A. V. Gordadze, C. W. Onunwor, R. Peng, D. Poston, E. Kremmer, and P. D. Ling (2004)
J. Virol. 78, 3919-3929
 |  Abstract »  |  Full Text »  |  PDF »

Role of NF-{kappa}B in Cell Survival and Transcription of Latent Membrane Protein 1-Expressing or Epstein-Barr Virus Latency III-Infected Cells.

E. D. Cahir-McFarland, K. Carter, A. Rosenwald, J. M. Giltnane, S. E. Henrickson, L. M. Staudt, and E. Kieff (2004)
J. Virol. 78, 4108-4119
 |  Abstract »  |  Full Text »  |  PDF »

Mitosis-Specific Hyperphosphorylation of Epstein-Barr Virus Nuclear Antigen 2 Suppresses Its Function.

W. Yue, M. G. Davenport, J. Shackelford, and J. S. Pagano (2004)
J. Virol. 78, 3542-3552
 |  Abstract »  |  Full Text »  |  PDF »

Inhibition of Epstein-Barr virus-induced growth proliferation by a nuclear antigen EBNA2-TAT peptide.

C. J. Farrell, J. M. Lee, E.-C. Shin, M. Cebrat, P. A. Cole, and S. D. Hayward (2004)
PNAS 101, 4625-4630
 |  Abstract »  |  Full Text »  |  PDF »

RING1 inhibits transactivation of RBP-J by Notch through interaction with LIM protein KyoT2.

H. Qin, J. Wang, Y. Liang, Y. Taniguchi, K. Tanigaki, and H. Han (2004)
Nucleic Acids Res. 32, 1492-1501
 |  Abstract »  |  Full Text »  |  PDF »

Notch signaling: control of cell communication and cell fate.

E. C. Lai (2004)
Development 131, 965-973
 |  Abstract »  |  Full Text »  |  PDF »

Differential Effects of Drosophila Mastermind on Asymmetric Cell Fate Specification and Neuroblast Formation.

B. Yedvobnick, A. Kumar, P. Chaudhury, J. Opraseuth, N. Mortimer, and K. M. Bhat (2004)
Genetics 166, 1281-1289
 |  Abstract »  |  Full Text »  |  PDF »

Epstein-Barr Virus and Cancer.

M. P. Thompson and R. Kurzrock (2004)
Clin. Cancer Res. 10, 803-821
 |  Abstract »  |  Full Text »  |  PDF »

Direct interactions between Epstein-Barr virus leader protein LP and the EBNA2 acidic domain underlie coordinate transcriptional regulation.

C.-W. Peng, Y. Xue, B. Zhao, E. Johannsen, E. Kieff, and S. Harada (2004)
PNAS 101, 1033-1038
 |  Abstract »  |  Full Text »  |  PDF »

Epstein-Barr Virus Nuclear Protein EBNA3A Is Critical for Maintaining Lymphoblastoid Cell Line Growth.

S. Maruo, E. Johannsen, D. Illanes, A. Cooper, and E. Kieff (2003)
J. Virol. 77, 10437-10447
 |  Abstract »  |  Full Text »  |  PDF »

CCAAT/Enhancer-Binding Protein-{alpha} Is Induced during the Early Stages of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Lytic Cycle Reactivation and Together with the KSHV Replication and Transcription Activator (RTA) Cooperatively Stimulates the Viral RTA, MTA, and PAN Promoters.

S. E. Wang, F. Y. Wu, Y. Yu, and G. S. Hayward (2003)
J. Virol. 77, 9590-9612
 |  Abstract »  |  Full Text »  |  PDF »

Latent Membrane Protein 1 of Epstein-Barr Virus Induces CD83 by the NF-{kappa}B Signaling Pathway.

D. Dudziak, A. Kieser, U. Dirmeier, F. Nimmerjahn, S. Berchtold, A. Steinkasserer, G. Marschall, W. Hammerschmidt, G. Laux, and G. W. Bornkamm (2003)
J. Virol. 77, 8290-8298
 |  Abstract »  |  Full Text »  |  PDF »

Differential Hyperacetylation of Histones H3 and H4 upon Promoter-Specific Recruitment of EBNA2 in Epstein-Barr Virus Chromatin.

N. Alazard, H. Gruffat, E. Hiriart, A. Sergeant, and E. Manet (2003)
J. Virol. 77, 8166-8172
 |  Abstract »  |  Full Text »  |  PDF »

Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.

Y. Liang and D. Ganem (2003)
PNAS 100, 8490-8495
 |  Abstract »  |  Full Text »  |  PDF »

Transcriptional Regulatory Properties of Epstein-Barr Virus Nuclear Antigen 3C Are Conserved in Simian Lymphocryptoviruses.

B. Zhao, R. Dalbies-Tran, H. Jiang, I. K. Ruf, J. T. Sample, F. Wang, and C. E. Sample (2003)
J. Virol. 77, 5639-5648
 |  Abstract »  |  Full Text »  |  PDF »

EBNA2 and Activated Notch Induce Expression of BATF.

L. M. Johansen, C. D. Deppmann, K. D. Erickson, W. F. Coffin III, T. M. Thornton, S. E. Humphrey, J. M. Martin, and E. J. Taparowsky (2003)
J. Virol. 77, 6029-6040
 |  Abstract »  |  Full Text »  |  PDF »

A Positive Autoregulatory Loop of LMP1 Expression and STAT Activation in Epithelial Cells Latently Infected with Epstein-Barr Virus.

H. Chen, L. Hutt-Fletcher, L. Cao, and S. D. Hayward (2003)
J. Virol. 77, 4139-4148
 |  Abstract »  |  Full Text »  |  PDF »

Epstein-Barr Virus Nuclear Antigen 3C Recruits Histone Deacetylase Activity and Associates with the Corepressors mSin3A and NCoR in Human B-Cell Lines.

J. S. Knight, K. Lan, C. Subramanian, and E. S. Robertson (2003)
J. Virol. 77, 4261-4272
 |  Abstract »  |  Full Text »  |  PDF »

Growth Suppression of Pre-T Acute Lymphoblastic Leukemia Cells by Inhibition of Notch Signaling.

A. P. Weng, Y. Nam, M. S. Wolfe, W. S. Pear, J. D. Griffin, S. C. Blacklow, and J. C. Aster (2003)
Mol. Cell. Biol. 23, 655-664
 |  Abstract »  |  Full Text »  |  PDF »

EBNA3A Association with RBP-J{kappa} Down-Regulates c-myc and Epstein-Barr Virus-Transformed Lymphoblast Growth.

A. Cooper, E. Johannsen, S. Maruo, E. Cahir-McFarland, D. Illanes, D. Davidson, and E. Kieff (2002)
J. Virol. 77, 999-1010
 |  Abstract »  |  Full Text »  |  PDF »

Epstein-Barr Virus-Induced Changes in B-Lymphocyte Gene Expression.

K. L. Carter, E. Cahir-McFarland, and E. Kieff (2002)
J. Virol. 76, 10427-10436
 |  Abstract »  |  Full Text »  |  PDF »

The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway.

Y. Liang, J. Chang, S. J. Lynch, D. M. Lukac, and D. Ganem (2002)
Genes & Dev. 16, 1977-1989
 |  Abstract »  |  Full Text »  |  PDF »

The Human SNF5/INI1 Protein Facilitates the Function of the Growth Arrest and DNA Damage-inducible Protein (GADD34) and Modulates GADD34-bound Protein Phosphatase-1 Activity.

D. Y. Wu, D. C. Tkachuck, R. S. Roberson, and W. H. Schubach (2002)
J. Biol. Chem. 277, 27706-27715
 |  Abstract »  |  Full Text »  |  PDF »

The EBNA2 Polyproline Region Is Dispensable for Epstein-Barr Virus-Mediated Immortalization Maintenance.

A. V. Gordadze, D. Poston, and P. D. Ling (2002)
J. Virol. 76, 7349-7355
 |  Abstract »  |  Full Text »  |  PDF »

Epstein-Barr virus (EBV) subtype in EBV related oral squamous cell carcinoma in Okinawa, a subtropical island in southern Japan, compared with Kitakyushu and Kumamoto in mainland Japan.

M Higa, T Kinjo, K Kamiyama, T Iwamasa, T Hamada, and K Iyama (2002)
J. Clin. Pathol. 55, 414-423
 |  Abstract »  |  Full Text »  |  PDF »

Epstein-Barr virus nuclear antigen 5 inhibits pre-mRNA cleavage and polyadenylation.

M. Dufva, J. Flodin, A. Nerstedt, U. Ruetschi, and L. Rymo (2002)
Nucleic Acids Res. 30, 2131-2143
 |  Abstract »  |  Full Text »  |  PDF »

Notch2 is involved in the overexpression of CD23 in B-cell chronic lymphocytic leukemia.

R. Hubmann, J. D. Schwarzmeier, M. Shehata, M. Hilgarth, M. Duechler, M. Dettke, and R. Berger (2002)
Blood 99, 3742-3747
 |  Abstract »  |  Full Text »  |  PDF »

Expression of Transcription Factor AML-2 (RUNX3, CBF{alpha}-3) Is Induced by Epstein-Barr Virus EBNA-2 and Correlates with the B-Cell Activation Phenotype.

L. C. Spender, G. H. Cornish, A. Sullivan, and P. J. Farrell (2002)
J. Virol. 76, 4919-4927
 |  Abstract »  |  Full Text »  |  PDF »

Protein Kinase A Associates with HA95 and Affects Transcriptional Coactivation by Epstein-Barr Virus Nuclear Proteins.

I. Han, Y. Xue, S. Harada, S. Orstavik, B. Skalhegg, and E. Kieff (2002)
Mol. Cell. Biol. 22, 2136-2146
 |  Abstract »  |  Full Text »  |  PDF »

The Conserved Mynd Domain of BS69 Binds Cellular and Oncoviral Proteins through a Common PXLXP Motif.

S. Ansieau and A. Leutz (2002)
J. Biol. Chem. 277, 4906-4910
 |  Abstract »  |  Full Text »  |  PDF »

Conserved Region CR2 of Epstein-Barr Virus Nuclear Antigen Leader Protein Is a Multifunctional Domain That Mediates Self-Association as well as Nuclear Localization and Nuclear Matrix Association.

M. Tanaka, A. Yokoyama, M. Igarashi, G. Matsuda, K. Kato, M. Kanamori, K. Hirai, Y. Kawaguchi, and Y. Yamanashi (2002)
J. Virol. 76, 1025-1032
 |  Abstract »  |  Full Text »  |  PDF »

Epstein-Barr Virus Nuclear Antigen 3C Putative Repression Domain Mediates Coactivation of the LMP1 Promoter with EBNA-2.

J. Lin, E. Johannsen, E. Robertson, and E. Kieff (2002)
J. Virol. 76, 232-242
 |  Abstract »  |  Full Text »  |  PDF »

Genetic analysis of the Epstein-Barr virus-coded leader protein EBNA-LP as a co-activator of EBNA2 function.

E. M. McCann, G. L. Kelly, A. B. Rickinson, and A. I. Bell (2001)
J. Gen. Virol. 82, 3067-3079
 |  Abstract »  |  Full Text »  |  PDF »

Functional Cooperation of Epstein-Barr Virus Nuclear Antigen 2 and the Survival Motor Neuron Protein in Transactivation of the Viral LMP1 Promoter.

M. D. Voss, A. Hille, S. Barth, A. Spurk, F. Hennrich, D. Holzer, N. Mueller-Lantzsch, E. Kremmer, and F. A. Grasser (2001)
J. Virol. 75, 11781-11790
 |  Abstract »  |  Full Text »

A Functional Composite Cis-Element for NF{kappa}B and RBPJ{kappa} in the Rat Pregnancy-Specific Glycoprotein Gene.

C.-D. Wang, G.-D. Chang, Y.-K. Lee, and H. Chen (2001)
Biol Reprod 65, 1437-1443
 |  Abstract »  |  Full Text »  |  PDF »

The Latency-Associated Nuclear Antigen Encoded by Kaposi's Sarcoma-Associated Herpesvirus Activates Two Major Essential Epstein-Barr Virus Latent Promoters.

A. K. Groves, M. A. Cotter, C. Subramanian, and E. S. Robertson (2001)
J. Virol. 75, 9446-9457
 |  Abstract »  |  Full Text »  |  PDF »

DNA Binding and Modulation of Gene Expression by the Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus.

A. C. Garber, M. A. Shu, J. Hu, and R. Renne (2001)
J. Virol. 75, 7882-7892
 |  Abstract »  |  Full Text »  |  PDF »

Notch1IC Partially Replaces EBNA2 Function in B Cells Immortalized by Epstein-Barr Virus.

A. V. Gordadze, R. Peng, J. Tan, G. Liu, R. Sutton, B. Kempkes, G. W. Bornkamm, and P. D. Ling (2001)
J. Virol. 75, 5899-5912
 |  Abstract »  |  Full Text »  |  PDF »

Autostimulation of the Epstein-Barr Virus BRLF1 Promoter Is Mediated through Consensus Sp1 and Sp3 Binding Sites.

T. Ragoczy and G. Miller (2001)
J. Virol. 75, 5240-5251
 |  Abstract »  |  Full Text »

A site in the complement receptor 2 (CR2/CD21) silencer is necessary for lineage specific transcriptional regulation.

K. W. Makar, D. Ulgiati, J. Hagman, and V. M. Holers (2001)
Int. Immunol. 13, 657-664
 |  Abstract »  |  Full Text »  |  PDF »

Direct and Indirect Regulation of Cytokine and Cell Cycle Proteins by EBNA-2 during Epstein-Barr Virus Infection.

L. C. Spender, G. H. Cornish, B. Rowland, B. Kempkes, and P. J. Farrell (2001)
J. Virol. 75, 3537-3546
 |  Abstract »  |  Full Text »

Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 Mediates Episome Persistence through cis-Acting Terminal Repeat (TR) Sequence and Specifically Binds TR DNA.

M. E. Ballestas and K. M. Kaye (2001)
J. Virol. 75, 3250-3258
 |  Abstract »  |  Full Text »

Epstein-Barr Virus BamHI-A Rightward Transcript-Encoded RPMS Protein Interacts with the CBF1-Associated Corepressor CIR To Negatively Regulate the Activity of EBNA2 and NotchIC.

J. Zhang, H. Chen, G. Weinmaster, and S. D. Hayward (2001)
J. Virol. 75, 2946-2956
 |  Abstract »  |  Full Text »

The N- and C-terminal regions of RBP-J interact with the ankyrin repeats of Notch1 RAMIC to activate transcription.

S. Tani, H. Kurooka, T. Aoki, N. Hashimoto, and T. Honjo (2001)
Nucleic Acids Res. 29, 1373-1380
 |  Abstract »  |  Full Text »  |  PDF »

Activated Notch1 Can Transiently Substitute for EBNA2 in the Maintenance of Proliferation of LMP1-Expressing Immortalized B Cells.

H. Höfelmayr, L. J. Strobl, G. Marschall, G. W. Bornkamm, and U. Zimber-Strobl (2001)
J. Virol. 75, 2033-2040
 |  Abstract »  |  Full Text »

EBNA-LP Associates with Cellular Proteins Including DNA-PK and HA95.

I. Han, S. Harada, D. Weaver, Y. Xue, W. Lane, S. Orstavik, B. Skalhegg, and E. Kieff (2001)
J. Virol. 75, 2475-2481
 |  Abstract »  |  Full Text »

Epstein-Barr Virus Nuclear Protein 2 Has at Least Two N-Terminal Domains That Mediate Self-Association.

S. Harada, R. Yalamanchili, and E. Kieff (2001)
J. Virol. 75, 2482-2487
 |  Abstract »  |  Full Text »

Activation of the Notch-regulated transcription factor CBF1/RBP-J{kappa} through the 13SE1A oncoprotein.

S. Ansieau, L. J. Strobl, and A. Leutz (2001)
Genes & Dev. 15, 380-385
 |  Abstract »  |  Full Text »

Amino Acids of Epstein-Barr Virus Nuclear Antigen 3A Essential for Repression of J{kappa}-Mediated Transcription and Their Evolutionary Conservation.

R. Dalbiès-Tran, E. Stigger-Rosser, T. Dotson, and C. E. Sample (2001)
J. Virol. 75, 90-99
 |  Abstract »  |  Full Text »

An Epstein-Barr Virus Protein Interacts with Notch.

S. Kusano and N. Raab-Traub (2001)
J. Virol. 75, 384-395
 |  Abstract »  |  Full Text »

The Epstein-Barr Virus Promoter Initiating B-Cell Transformation Is Activated by RFX Proteins and the B-Cell-Specific Activator Protein BSAP/Pax5.

R. Tierney, H. Kirby, J. Nagra, A. Rickinson, and A. Bell (2000)
J. Virol. 74, 10458-10467
 |  Abstract »  |  Full Text »

Methylation of Transcription Factor Binding Sites in the Epstein-Barr Virus Latent Cycle Promoter Wp Coincides with Promoter Down-Regulation during Virus-Induced B-Cell Transformation.

R. J. Tierney, H. E. Kirby, J. K. Nagra, J. Desmond, A. I. Bell, and A. B. Rickinson (2000)
J. Virol. 74, 10468-10479
 |  Abstract »  |  Full Text »

Promoter-Specific Targeting of Human SWI-SNF Complex by Epstein-Barr Virus Nuclear Protein 2.

D. Y. Wu, A. Krumm, and W. H. Schubach (2000)
J. Virol. 74, 8893-8903
 |  Abstract »  |  Full Text »

The expression and function of Epstein-Barr virus encoded latent genes.

L S Young, C W Dawson, and A G Eliopoulos (2000)
Mol. Pathol. 53, 238-247
 |  Abstract »  |  Full Text »

Regulation of the Epstein-Barr Virus C Promoter by AUF1 and the Cyclic AMP/Protein Kinase A Signaling Pathway.

E. M. Fuentes-Pananá, R. Peng, G. Brewer, J. Tan, and P. D. Ling (2000)
J. Virol. 74, 8166-8175
 |  Abstract »  |  Full Text »

Epstein-Barr Virus Nuclear Antigen 3C Activates the Latent Membrane Protein 1 Promoter in the Presence of Epstein-Barr Virus Nuclear Antigen 2 through Sequences Encompassing an Spi-1/Spi-B Binding Site.

B. Zhao and C. E. Sample (2000)
J. Virol. 74, 5151-5160
 |  Abstract »  |  Full Text »

Functional interactions between an atypical NF-{kappa}B site from the rat CYP2B1 promoter and the transcriptional repressor RBP-J{kappa}/CBF1.

S. H. Lee, X.-l. Wang, and J. DeJong (2000)
Nucleic Acids Res. 28, 2091-2098
 |  Abstract »  |  Full Text »  |  PDF »

Structure and Coding Content of CST (BART) Family RNAs of Epstein-Barr Virus.

P. R. Smith, O. de Jesus, D. Turner, M. Hollyoake, C. E. Karstegl, B. E. Griffin, L. Karran, Y. Wang, S. D. Hayward, and P. J. Farrell (2000)
J. Virol. 74, 3082-3092
 |  Abstract »  |  Full Text »

Activated Notch1 Modulates Gene Expression in B Cells Similarly to Epstein-Barr Viral Nuclear Antigen 2.

L. J. Strobl, H. Höfelmayr, G. Marschall, M. Brielmeier, G. W. Bornkamm, and U. Zimber-Strobl (2000)
J. Virol. 74, 1727-1735
 |  Abstract »  |  Full Text »

A Role for SKIP in EBNA2 Activation of CBF1-Repressed Promoters.

S. Zhou, M. Fujimuro, J. J.-D. Hsieh, L. Chen, and S. D. Hayward (2000)
J. Virol. 74, 1939-1947
 |  Abstract »  |  Full Text »

Intracellular Forms of Human NOTCH1 Functionally Activate Essential Epstein-Barr Virus Major Latent Promoters in the Burkitt's Lymphoma BJAB Cell Line but Repress These Promoters in Jurkat Cells.

M. Cotter, J. Callahan, J. Aster, and E. Robertson (2000)
J. Virol. 74, 1486-1494
 |  Abstract »  |  Full Text »

Repression by Suppressor of Hairless and activation by Notch are required to define a single row of single-minded expressing cells in the Drosophila embryo.

V. Morel and F. Schweisguth (2000)
Genes & Dev. 14, 377-388
 |  Abstract »  |  Full Text »

Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter.

L. Wang, S. R. Grossman, and E. Kieff (2000)
PNAS 97, 430-435
 |  Abstract »  |  Full Text »  |  PDF »

Sequence and Functional Analysis of EBNA-LP and EBNA2 Proteins from Nonhuman Primate Lymphocryptoviruses.

R. Peng, A. V. Gordadze, E. M. Fuentes Pananá, F. Wang, J. Zong, G. S. Hayward, J. Tan, and P. D. Ling (2000)
J. Virol. 74, 379-389
 |  Abstract »  |  Full Text »

Genetic Dissection of Cell Growth Arrest Functions Mediated by the Epstein-Barr Virus Lytic Gene Product, Zta.

A. Rodriguez, M. Armstrong, D. Dwyer, and E. Flemington (1999)
J. Virol. 73, 9029-9038
 |  Abstract »  |  Full Text »  |  PDF »

Strong Selective Pressure for Evolution of an Epstein-Barr Virus LMP2B Homologue in the Rhesus Lymphocryptovirus.

P. Rivailler, C. Quink, and F. Wang (1999)
J. Virol. 73, 8867-8872
 |  Abstract »  |  Full Text »  |  PDF »

Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors.

S. Jayachandra, K. G. Low, A.-E. Thlick, J. Yu, P. D. Ling, Y. Chang, and P. S. Moore (1999)
PNAS 96, 11566-11571
 |  Abstract »  |  Full Text »  |  PDF »

Characterization of DP103, a Novel DEAD Box Protein That Binds to the Epstein-Barr Virus Nuclear Proteins EBNA2 and EBNA3C.

A. T. Grundhoff, E. Kremmer, O. Tureci, A. Glieden, C. Gindorf, J. Atz, N. Mueller-Lantzsch, W. H. Schubach, and F. A. Grasser (1999)
J. Biol. Chem. 274, 19136-19144
 |  Abstract »  |  Full Text »  |  PDF »

Epstein-Barr Virus Nuclear Antigen 3C Interacts with Histone Deacetylase To Repress Transcription.

S. A. Radkov, R. Touitou, A. Brehm, M. Rowe, M. West, T. Kouzarides, and M. J. Allday (1999)
J. Virol. 73, 5688-5697
 |  Abstract »  |  Full Text »

Epstein-Barr Virus (EBV) Nuclear Protein 2-Induced Disruption of EBV Latency in the Burkitt's Lymphoma Cell Line Akata: Analysis by Tetracycline-Regulated Expression.

S. Fujiwara, Y. Nitadori, H. Nakamura, T. Nagaishi, and Y. Ono (1999)
J. Virol. 73, 5214-5219
 |  Abstract »  |  Full Text »

The Proto-Oncogene c-myc Is a Direct Target Gene of Epstein-Barr Virus Nuclear Antigen 2.

C. Kaiser, G. Laux, D. Eick, N. Jochner, G. W. Bornkamm, and B. Kempkes (1999)
J. Virol. 73, 4481-4484
 |  Abstract »  |  Full Text »

Activated Mouse Notch1 Transactivates Epstein-Barr Virus Nuclear Antigen 2-Regulated Viral Promoters.

H. Höfelmayr, L. J. Strobl, C. Stein, G. Laux, G. Marschall, G. W. Bornkamm, and U. Zimber-Strobl (1999)
J. Virol. 73, 2770-2780
 |  Abstract »  |  Full Text »

CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex.

J. J.-D. Hsieh, S. Zhou, L. Chen, D. B. Young, and S. D. Hayward (1999)
PNAS 96, 23-28
 |  Abstract »  |  Full Text »  |  PDF »

Mta Has Properties of an RNA Export Protein and Increases Cytoplasmic Accumulation of Epstein-Barr Virus Replication Gene mRNA.

O. J. Semmes, L. Chen, R. T. Sarisky, Z. Gao, L. Zhong, and S. D. Hayward (1998)
J. Virol. 72, 9526-9534
 |  Abstract »  |  Full Text »  |  PDF »

Residues 231 to 280 of the Epstein-Barr Virus Nuclear Protein 2 Are Not Essential for Primary B-Lymphocyte Growth Transformation.

S. Harada, R. Yalamanchili, and E. Kieff (1998)
J. Virol. 72, 9948-9954
 |  Abstract »  |  Full Text »  |  PDF »

To Advertise   |   Find Products